Cirrhosis with steatohepatitis after adjuvant tamoxifen

Lancet

Volumn 353, Issue 9146, 1999, Pages 36-37

  Oien, Karin A ^a   Moffat, David ^b   Curry, Graham W ^b   Dickson, Jeanette ^b   Habeshaw, Tim ^b   Mills, Peter R ^b   MacSween, Roderick N M ^b  

^a BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; FATTY LIVER; FEMALE; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; PATIENT MONITORING; PRIORITY JOURNAL;

EID: 0033514076     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)74872-8     Document Type: Article

References (5)

1. 1 Ogawa Y, Murata Y, Nishioka A, Inomata T, Yoshida S. Tamoxifen-induced fatty liver in patients with breast cancer. Lancet 1998; 351: 725.
2. 2 Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-09.
3. 3 Pratt DS, Knox TA, Erban J. Tamoxifen-Induced Steatohepatitis. Ann Intern Med 1995; 123: 236.
4. 4 Pinto HC, Baptista A, Camilo ME, De Costa EB, Valente A, De Moura MC. Tamoxifen-associated steatohepatitis: report of three cases. J Hepatol 1995; 23: 95-97.
5. 5 Van Hoof M, Rahier J, Horsmans Y. Tamoxifen-Induced Steatohepatitis. Ann Intern Med 1996; 124: 855-56.